Literature DB >> 29192768

Mavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C InfectionPublished as part of the Biochemistry series "Biochemistry to Bedside".

Ashley N Matthew1, Nese Kurt Yilmaz1, Celia A Schiffer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29192768     DOI： 10.1021/acs.biochem.7b01160

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  2 in total

1.  Glecaprevir/pibrentasvir-associated acute liver injury in non-cirrhotic, chronic HCV infection without HBV co-infection.

Authors:  Muhammad Baraa Hammami; Reem Aboushaar; Eyad Alsabbagh
Journal:  BMJ Case Rep       Date:  2019-05-24

2.  Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.

Authors:  Laura Riva; Shuofeng Yuan; Xin Yin; Laura Martin-Sancho; Naoko Matsunaga; Lars Pache; Sebastian Burgstaller-Muehlbacher; Paul D De Jesus; Peter Teriete; Mitchell V Hull; Max W Chang; Jasper Fuk-Woo Chan; Jianli Cao; Vincent Kwok-Man Poon; Kristina M Herbert; Kuoyuan Cheng; Tu-Trinh H Nguyen; Andrey Rubanov; Yuan Pu; Courtney Nguyen; Angela Choi; Raveen Rathnasinghe; Michael Schotsaert; Lisa Miorin; Marion Dejosez; Thomas P Zwaka; Ko-Yung Sit; Luis Martinez-Sobrido; Wen-Chun Liu; Kris M White; Mackenzie E Chapman; Emma K Lendy; Richard J Glynne; Randy Albrecht; Eytan Ruppin; Andrew D Mesecar; Jeffrey R Johnson; Christopher Benner; Ren Sun; Peter G Schultz; Andrew I Su; Adolfo García-Sastre; Arnab K Chatterjee; Kwok-Yung Yuen; Sumit K Chanda
Journal:  Nature       Date:  2020-07-24       Impact factor: 69.504
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.